Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1235 |
| Name of the vaccine | VLA84 |
| Microbe | Bacteria |
| Disease name | Clostridium Difficile Infection |
| Name of bacteria | Clostridium difficile |
| Type of vaccine | Recombinant |
| Nucleic acid content | Linear DNA |
| Age | 50 years and older |
| Description of the vaccine | Recombinant fusion protein consisting of truncated Clostridium difficile toxin A and toxin B. |
| Name of the manufacturer | Valneva Austria GmbH |
| Name of the manufacturing country | Germany, United States |
| Year of manufacture | 2015 |
| Clinical Phase status | Clinical - Phase 2 |
| Bacterial strain | Gram-positive bacillus. |
| Efficacy | NA |
| Vaccine formulation | Suspension for injection |
| Dosage | Different combinations of doses. |
| Mechanism of action | NA |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | With or without Alum |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT02316470 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |